Yuqin Wang
Research Subjects
Yuqin Wang has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Alexandra Y. Kreins
Great Ormond Street Institute of Child Health, University College London 11 Infection, Immunity and Inflammation, Research & Teaching Department London
1 shared publication - Angelique Sanchez Dafun
Université de Toulouse, CNRS, IPBS, Toulouse, France
1 shared publication - Arndt Borkhardt
Department of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty Heinrich Heine University Düsseldorf Düsseldorf Germany
1 shared publication - Christoph Klein
Department of Pediatrics, Dr. von Hauner Children’s Hospital, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany
1 shared publication - Christoph Schultheiß
Division of Medical Oncology, University Hospital Basel, Basel, Switzerland
1 shared publication - Clara Soulard
University of Montreal 9 Pediatric Immunology and Rheumatology Division, CHU Sainte-Justine, Department of Pediatrics Montreal, Quebec
1 shared publication
Latest Publications
- Open Access
- 9 April 2026
- Published by Rockefeller University Press in Journal of Human Immunity
- Vol. 2 (3)
Dominant-negative PSMB10 disrupts immunoproteasome assembly and leads to transient T lymphopenia
Immunoproteasomes are specialized multiprotein proteases that degrade intracellular proteins. Their products serve as peptides for human leukocyte antigen class I presentation playing a key role in antiviral defense and self-tolerance. Monoallelic variants in immunoproteasome genes including proteasome subunit β type 10 have recently been associated with autoinflammatory diseases and severe combined immune deficiency. Their pathophysiological consequences remain poorly understood, and treatment options are scarce. We identified a newborn with severe T lymphopenia and a de novo dominant-negative PSMB10 p.G209R mutation after pathological T cell receptor excision circle newborn screening. We further applied molecular modeling, proteomics, transcriptomics, and ex vivo T lymphopoiesis. Simulations predicted, and biochemical studies confirmed, impaired immunoproteasome assembly and function leading to defective viral sensing and antigen presentation signatures in interferon-treated fibroblasts. Despite this, hematopoietic stem cells differentiated into T cells ex vivo, and the patient developed normal naïve T cell counts and a diverse T cell antigen receptor repertoire within the first year of life in contrast to all previously reported patients.
- 9 April 2026
- Published by Rockefeller University Press in Journal of Human Immunity
- Vol. 2 (3)
Open AccessDominant-negative PSMB10 disrupts immunoproteasome assembly and leads to transient T lymphopenia
Immunoproteasomes are specialized multiprotein proteases that degrade intracellular proteins. Their products serve as peptides for human leukocyte antigen class I presentation playing a key role in antiviral defense and self-tolerance. Monoallelic variants in immunoproteasome genes including proteasome subunit β type 10 have recently been associated with autoinflammatory diseases and severe combined immune deficiency. Their pathophysiological consequences remain poorly understood, and treatment options are scarce. We identified a newborn with severe T lymphopenia and a de novo dominant-negative PSMB10 p.G209R mutation after pathological T cell receptor excision circle newborn screening. We further applied molecular modeling, proteomics, transcriptomics, and ex vivo T lymphopoiesis. Simulations predicted, and biochemical studies confirmed, impaired immunoproteasome assembly and function leading to defective viral sensing and antigen presentation signatures in interferon-treated fibroblasts. Despite this, hematopoietic stem cells differentiated into T cells ex vivo, and the patient developed normal naïve T cell counts and a diverse T cell antigen receptor repertoire within the first year of life in contrast to all previously reported patients.